Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2011. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's American Depositary Receipt (ADR) shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
The only material change disclosed is a reduction in the shareholding of a senior executive. Mr. W C Louv sold 1,722 ADR shares of GlaxoSmithKline plc on August 25, 2011, at a price of $42.71 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: August 25, 2011
- Executive: Mr. W C Louv (Person Discharging Managerial Responsibility)
- Action: Sale of 1,722 ADR shares
- Price: $42.71 per share
- Reporting Date: August 26, 2011